组氨酸-色氨酸-酮戊二酸液与林格液肾灌注在开放胸腹主动脉修复术中的比较
OBJECTIVE: The objective of this study was to compare the efficacy of renal perfusion with Custodiol (Dr Franz-Kohler Chemie GmbH, Bensheim, Germany) versus enriched Ringer's solution for renal protection in patients undergoing open thoracoabdominal aortic aneurysm (TAAA) repair.…
要点
- Custodiol肾灌注可显著降低开放TAAA修复术后AKI发生率(48.9% vs 75.6%)。
- Custodiol是AKI的独立保护因素(OR 0.230,95%CI 0.086-0.614)。
- II型TAAA与严重AKI风险增加独立相关(OR 4.277,95%CI 1.239-14.762)。
核心结论
- 开放TAAA修复中使用Custodiol安全,且术后AKI发生率显著低于林格液。
- 研究结果支持Custodiol在该场景中的安全性和有效性,尽管目前属于超说明书使用。
研究设计与样本
- 患者随机接受4°C Custodiol(n=45)或4°C乳酸林格液(n=45)肾动脉灌注。
- 主要终点为急性肾损伤(AKI)发生率。
主要发现
- 1年随访时,两组血清肌酐与术前值无显著差异。
临床怎么用
- 在开放TAAA修复中可考虑使用4°C Custodiol进行肾动脉灌注以降低术后AKI风险。
- 需注意Custodiol在该适应症中属于超说明书使用,应结合患者具体情况和团队经验决策。
局限性
- 随访1年时血清肌酐与术前无显著差异,但未报告更长期肾功能结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to compare the efficacy of renal perfusion with Custodiol (Dr Franz-Kohler Chemie GmbH, Bensheim, Germany) versus enriched Ringer's solution for renal protection in patients undergoing open thoracoabdominal aortic aneurysm (TAAA) repair. METHODS: Ninety consecutive patients scheduled for elective open TAAA repair were enrolled between 2015 and 2017 in a single-center, phase IV, prospective, parallel, randomized, double-blind trial (the CUstodiol versus RInger: whaT Is the Best Agent [CURITIBA] trial), and randomized to renal arteries perfusion with 4°C Custodiol (Dr Franz-Kohler Chemie GmbH, Bensheim, Germany; n = 45) or 4°C lactated Ringer's solution (n = 45). The incidence of acute kidney injury (AKI) in patients undergoing TAAA open surgery using Custodiol renal perfusion versus an enriched Ringer's solution was the primary end point. RESULTS: Ninety patients completed the study (45 patients in each group). The incidence of postoperative AKI was significantly lower in the Custodiol group (48.9% vs 75.6%; P = .02). In the multivariable model, only the use of Custodiol solution resulted as protective from the occurrence of any AKI (odds ratio, 0.230; 95% confidence interval, 0.086-0.614; P = .003), whereas TAAA type II extent was associated with the development of severe AKI (odds ratio, 4.277; 95% confidence interval, 1.239-14.762; P = .02). At 1-year follow-up, serum creatinine was not significantly different from the preoperative values in both groups. CONCLUSIONS: The use of Custodiol during open TAAA repair was safe and resulted in significantly lower rates of postoperative AKI compared with Ringer's solution. These findings support safety and efficacy of Custodiol in this specific setting, which is currently off-label.
引用
- Kahlberg A, Tshomba Y, Baccellieri D, et al. Renal perfusion with histidine-tryptophan-ketoglutarate compared with Ringer's solution in patients undergoing thoracoabdominal aortic open repair. J Thorac Cardiovasc Surg. 2021. PMID: 33820636. doi:10.1016/j.jtcvs.2021.02.090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。